Richard Scolyer, a 59-year-old Australian cancer specialist and co-medical director at Melanoma Institute Australia, passed away after a battle with glioblastoma, a highly aggressive brain cancer. His death has sparked an outpouring of tributes for his significant contributions to melanoma treatment, which transformed advanced melanoma into a manageable condition through groundbreaking immunotherapy techniques. Recently named joint 2024 Australian of the Year, Scolyer bravely participated in a pioneering experimental treatment that utilized immunotherapy insights from his own field. This innovative approach involved administering immunotherapy prior to surgery, a method developed by his collaborator Dr. Georgina Long. Scolyer documented his illness publicly, expressing a desire to shed light on the experiences of cancer patients and inspire hope for ongoing research. Prime Minister Anthony Albanese honored Scolyer's legacy, describing him as a beacon of hope and announcing that a chair at the Chris O'Brien Lifehouse cancer center would be named after him. Scolyer is survived by his wife and three children.